U.S. Tobacco Stock News

Essent Group stock jumped 4.9% to US$68.72 after earnings, a strong move for a mortgage insurer that investors usually treat as a slow compounder rather than a trading vehicle. The headline is simple: profitability held up and the balance sheet stayed thick with capital even as net profit margin over the past year sat at 51.5%, below the earlier 56.4% level investors had grown used to. Short term traders see a pop. Long term holders see a company earning US$2.09 per share this quarter while...

In late July 2026, Align Technology reported second-quarter 2026 results showing sales rising to US$1,056.19 million year-on-year, issued softer sequential revenue guidance for the third quarter, and outlined the impact of one-time restructuring, depreciation, and legal charges on its GAAP operating margin outlook. At the same time, after discussions with Elliott Investment Management, Align committed to appoint three new independent directors, launched a comprehensive strategic and...

With the Iran war disrupting the Strait of Hormuz, inflation staying stubbornly high and rate hikes still on the table, many investors are questioning how much risk is really baked into today’s lofty valuations. Periods like this can punish fragile business models but also reveal sturdier ones. This article focuses on 3 large cap value stocks that screens suggest are more exposed to these shocks, and explains what that could mean for your portfolio decisions. The three stocks below are only a...

In early August 2026, Perma-Fix Environmental Services announced it had formed a partnership with Mirion Technologies under the SBA Mentor-Protégé Program to jointly pursue U.S. Department of Energy nuclear cleanup and advanced waste characterization projects. This collaboration pairs Perma-Fix’s nuclear waste treatment and remediation capabilities with Mirion’s radiation detection and measurement expertise, potentially deepening Mirion’s role in long-duration federal cleanup work. We’ll now...

FIGS stock has delivered a very strong 129.3% return over the past year, yet its valuation checks still suggest the shares are not an obvious bargain. Recent optimism around growth and profitability now sits alongside a low overall value score and an assessment that the stock screens as overvalued on market multiples. The 129.3% one year return signals that expectations around FIGS have shifted quickly and that recent buyers are paying a much higher price than they were a year ago. Stronger...

Ferguson Enterprises Inc. recently announced that its Board of Directors declared a quarterly dividend of US$0.89 per share, payable on October 7, 2026, to shareholders of record as of August 21, 2026, with a September 10, 2026 currency election deadline for Depositary Interest holders. Alongside this dividend, Ferguson has been added to the S&P 500 and multiple related S&P indices, a shift that can influence how index funds and institutional investors position the stock within diversified...

In the second quarter of 2026, Biogen Inc. reported revenue of US$2,736.0 million, up from US$2,645.5 million a year earlier, while net income fell to US$97.5 million and diluted earnings per share from continuing operations declined to US$0.66 from US$4.33. Despite higher sales and revenue, Biogen’s earnings compressed significantly, even as its newer therapies outpaced its legacy multiple sclerosis portfolio and the Apellis acquisition expanded its growth product lineup. We’ll now examine...

Why Manhattan Associates Stock Is Back In Focus Manhattan Associates (MANH) has jumped back onto investor watchlists after a golden cross pattern coincided with fresh 2026 earnings guidance and an updated read on recent quarterly results. This mix of technical and fundamental news gives you several angles to assess the stock. Recent guidance, the latest earnings report and ongoing capital allocation moves all feed into how you might think about risk and reward here. See our latest analysis...

TOMS Capital’s no confidence campaign against Voya Financial (VOYA) has moved into a new phase, with a definitive proxy filing and an open letter challenging the board’s decisions, recent execution, and approach to potential third party interest. See our latest analysis for Voya Financial. At a share price of US$101.40, Voya Financial has delivered a 26.54% 90 day share price return and a 46.36% 1 year total shareholder return. This suggests recent momentum has been strong despite the fresh...

D.R. Horton stock has delivered a 62.8% gain over the past five years, yet both the Discounted Cash Flow (DCF) intrinsic value estimate and earnings multiples currently point to the shares trading below what those frameworks suggest as fair. Over the last five years, D.R. Horton has returned 62.8%, which means long term holders have already seen solid value creation even before considering today’s valuation signals. Market expectations for future housing demand and construction activity can...

ANI Pharmaceuticals just took a 5.3% hit in a single session, yet the earnings story looks more like growing pains than a broken thesis. You have a stock that came into the print soft over the past month, then sold off again right after reporting adjusted earnings per share of US$2.21 on revenue of US$266.0m. The real swing factor is profit quality. Investors appear to be wrestling with how much of the recent profitability and trailing US$259.6m of adjusted EBITDA reflects repeatable rare...

Why APA earnings and guidance matter for investors now APA (APA) reported second quarter 2026 results on 5 August, with earnings per share above analyst expectations even as revenue was lower than a year ago. The company also raised U.S. oil production guidance, increased its 2026 cost savings target, and reaffirmed plans for shareholder returns and future exploration. These announcements give you several concrete data points to weigh. You can compare reported revenue and profit to your...

Embecta entered this quarter wearing the label of a deeply discounted diabetes device stock, with a single digit P/E and significant balance sheet questions. The market lifted the share price 26% to US$4.42 in the first session after earnings. The move reflects one headline takeaway: the business reported a sharp rebound in both revenue and profit, with Q3 sales of US$271.7m and net income of US$21.1m after a loss in Q2. For a company under pressure over debt and cash generation, that...

How PayPal's Latest Earnings Set the Stage for Investors PayPal Holdings (PYPL) just reported second quarter 2026 results, with sales of US$8.68b and net income of US$1.10b, giving investors a mixed update on growth and profitability. Sales for the first half of 2026 reached US$17.04b, while net income for the same period came in at US$2.22b. Earnings per share from continuing operations were lower than a year ago on both a basic and diluted basis. At the same time, PayPal Holdings (PYPL)...

In late July 2026, Laureate Education, Inc. reported second-quarter sales of US$615.86 million and net income of US$137.1 million, alongside higher first-half earnings and an updated full-year 2026 revenue outlook of US$1.92 billion to US$1.93 billion, implying 13% as-reported growth. At the same time, Laureate expanded its share repurchase effort, having already bought back 13,863,000 shares for US$399.61 million and adding a further US$250 million authorization, highlighting management’s...

In early August 2026, IonQ reported record second-quarter sales of US$80.05 million, raised its full-year 2026 revenue outlook to US$280–290 million, and secured a US$28 million DARPA contract extension to deliver 125 Evergreen-05 optical atomic clocks for mission-critical U.S. government applications while committing US$15 million to expand production capacity. Together with new federal collaborations in quantum communications and security, these developments highlight IonQ’s growing role...

Under Armour stock fell about 4.5% to US$6.11 in the first trading session after its Q1 2027 report, adding fresh pressure to an already weak one month stretch. At first glance the reaction looks harsh for a company that just posted a small profit and stronger than expected adjusted operating income. The real headline is not the quarter. It is the decision to cut full year revenue guidance to a mid single digit decline while still holding the US$140 million to US$160 million adjusted...

Western Digital (NasdaqGS:WDC) has secured long-term AI storage agreements with hyperscale customers that run through 2031. The contracts provide Western Digital with improved visibility on future demand for its storage products tied to AI workloads. The extended commitments indicate continued interest from large AI infrastructure buyers in Western Digital's technology platform. The company expects these agreements to reduce uncertainty around capacity planning for AI related storage through...

How Independence Realty Trust’s latest earnings update shapes the current picture Independence Realty Trust (IRT) released second quarter and first half 2026 results on 3 August, alongside a reaffirmed full year earnings outlook that keeps the focus on how its apartment portfolio is performing. The company reported second quarter sales of US$167.13 million and revenue of US$167.24 million, compared with US$161.89 million and US$162.19 million a year earlier. Net income for the quarter was...

Praxis Precision Medicines (NasdaqGS: PRAX) reported new clinical and regulatory milestones across its central nervous system pipeline, including progress on several drug candidates. The company received FDA Breakthrough Therapy designation for Elsunersen, its investigational treatment for neurological disorders. Praxis expanded its CNS program through collaborations and licensing agreements with partners including RogCon Inc. and Ionis Pharmaceuticals. This kind of pipeline and partnership...

CDW Corporation recently reported second-quarter 2026 results showing year-over-year growth in sales to US$6,572.2 million and higher earnings per share, alongside the Board declaring a quarterly dividend of US$0.630 per share payable on September 10, 2026. At the same time, long-serving Chief Financial Officer Albert J. Miralles disclosed plans to retire in 2027 while remaining through March 2028 as Executive Advisor, supporting CDW’s growth initiatives, investor relations, M&A, and...

Century Aluminum stock has delivered a very large 3 year gain, yet it still screens as undervalued on Simply Wall St’s valuation checks. This sets up a clear question about how much upside may be left in the current price of US$51.23. Over the past 3 years the share price has risen by a very large amount, which puts more focus on whether recent returns can be supported by fundamentals. The completion of production restarts at Mt. Holly and Grundartangi can support revenue and earnings...

Tariff power that stretches up to 100% on key Russian energy importers puts trade relationships, inflation, and company cost structures back in the spotlight. That kind of policy shock can quickly separate potential winners from stocks that may struggle. This article walks through three U.S. utilities and infrastructure stocks that appear positioned on the positive side of this story and explains why their businesses could matter for your watchlist now. The stocks covered below are just a...

BridgeBio Pharma (BBIO) has drawn fresh attention after recent share price moves, with the stock closing at $84.48 on 6 August 2026. Investors are weighing this level against the company’s longer term return profile. See our latest analysis for BridgeBio Pharma. The latest move in BridgeBio Pharma’s share price builds on a 30.61% 90 day share price return and an 81.37% 1 year total shareholder return. However, the 30 day share price return of 1.64% shows some cooling in the very short...